FDA Approves LumiThera’s Valeda System as First Treatment for Dry AMD
Quick Summary •FDA Clearance: LumiThera’s Valeda system becomes the first FDA-approved treatment for dry age-related macular degeneration (AMD). •Technology: Utilizes photobiomodulation (PBM) therapy to stimulate